Researchers examined how a new hospital-wide program for monitoring antibiotic levels in patients' blood was working in a large Chinese hospital. The program, which started in June 2024, was used for 1,928 patients. The study looked back at over 2,300 drug level measurements to see how the program was being used and if it was helping keep drug levels in the right range.
They found that use of the monitoring program varied widely between hospital departments. For example, it was used for over 90% of patients in the Emergency Intensive Care Unit, but not at all in the Pediatrics department. Overall, only about 50% of the measured drug concentrations were within the desired therapeutic range. For a common antibiotic called piperacillin, the success rate was even lower, at about 31%. However, for another antibiotic, moxifloxacin, the rate was much higher at 86%.
The study noted that drug levels that were too low were most common in hematology (blood disorder) patients, while levels that were too high were concentrated in intensive care units. The researchers suggested that the simple monitoring strategy used might not be detailed enough for very sick patients. No safety concerns were specifically reported. The main reason to be careful with these results is that this was a single-hospital study looking at past data, so we don't know if other hospitals would see the same patterns. Readers should understand this as an early look at the real-world challenges of implementing a complex hospital program, not as proof of its effectiveness or failure.
